Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Aaron M Tejani"'
Publikováno v:
BMJ Open, Vol 10, Iss 3 (2020)
BackgroundDiscrepancies in outcome reporting (DOR) between protocol and published studies include inclusions of new outcomes, omission of prespecified outcomes, upgrade and downgrade of secondary and primary outcomes, and changes in definitions of pr
Externí odkaz:
https://doaj.org/article/9e63d5f1833d46f78dbc151dc09624ac
Publikováno v:
Can J Hosp Pharm
Background: Many antimicrobials given by the intravenous (IV) route have oral (PO) formulations with high oral bioavailability. The advantages of using the PO rather than the IV formulation include lower risk of adverse reactions, shorter length of h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b89024f1194ae6769268210ae11f8722
https://europepmc.org/articles/PMC8956462/
https://europepmc.org/articles/PMC8956462/
Publikováno v:
Journal of Evaluation in Clinical Practice. 26:1699-1702
Rationale Some drugs can only be dispensed in multiple-dose containers. Multiple-dose packaging may pose a problem for hospitals in terms of drug wastage and cost. Oral inhalers, such as fluticasone propionate and salmeterol combination inhalers, are
Publikováno v:
Can Pharm J (Ott)
Publikováno v:
Journal of Evaluation in Clinical Practice. 26:18-25
Rationale, aims, and objectives The majority of hospitalized nonsurgical medical patients receive pharmacological prophylaxis for venous thromboembolism (VTE), and reassessment of changes in thrombosis and bleeding risk factors during hospital admiss
Publikováno v:
Aging Medicine, Vol 2, Iss 2, Pp 112-117 (2019)
Aging Medicine
Aging Medicine
Objective Long‐term use of proton pump inhibitors (PPIs) has been associated with an increased risk of harm. There are few studies evaluating pharmacist‐led PPI deprescribing interventions within a long‐term care facility setting. The aim of th
Publikováno v:
Can J Hosp Pharm
Previous studies have quantified wastage involving drugs that are available in multiple-dose formats. Ipratropium bromide by metered dose inhaler (MDI) is commonly used in hospitals, and may be contributing to waste of pharmaceutical and financial re
Publikováno v:
Canadian Journal of Hospital Pharmacy. 74
Background: Previous studies have quantified wastage involving drugs that are available in multiple-dose formats. Ipratropium bromide by metered dose inhaler (MDI) is commonly used in hospitals, and may be contributing to waste of pharmaceutical and
Autor:
Kevin Kwok, Aaron M Tejani
Publikováno v:
The Canadian Journal of Hospital Pharmacy. 73
Publikováno v:
BMJ Open
BMJ Open, Vol 10, Iss 3 (2020)
Shah, K, Egan, G, Huan, L, Kirkham, J, Reid, E & Tejani, A M 2020, ' Outcome reporting bias in Cochrane systematic reviews: a cross-sectional analysis ', BMJ Open . https://doi.org/10.1136/bmjopen-2019-032497
BMJ Open, Vol 10, Iss 3 (2020)
Shah, K, Egan, G, Huan, L, Kirkham, J, Reid, E & Tejani, A M 2020, ' Outcome reporting bias in Cochrane systematic reviews: a cross-sectional analysis ', BMJ Open . https://doi.org/10.1136/bmjopen-2019-032497
BackgroundDiscrepancies in outcome reporting (DOR) between protocol and published studies include inclusions of new outcomes, omission of prespecified outcomes, upgrade and downgrade of secondary and primary outcomes, and changes in definitions of pr